Despite a clear effort by conference organizers to embrace presentations on new resynchronization/pacing technologies and other interventional technology developments, the annual Transcatheter Cardiovascular Therapeutics (TCT) Symposium held here in mid-September served as a clear demonstration that stents – specifically the new generation of drug-eluting models – are a dominant discussion topic, both among clinicians and an industry that is embracing drug-coated implants as The Next Big Thing in medical technology.